BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research

German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies. HEIDELBERG, GERMANY / ACCESSWIRE / December 19, 2023 / BioMed X announced today a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research […]

Read More

MAXIMANCE 2030 LTD Backs BlueGrace Energy Bolivia in Groundbreaking Project, Fulfilling Over 90% of UN Sustainable Development Goals (SDG) while Pioneering Bolivia’s Rainforest Conservation as the Largest Initiative of Its Kind.

LONDON, UK / ACCESSWIRE / November 6, 2023 / In anticipation of the COP28 world climate summit to take place from 30 November to 12 December 2023 in Dubai, United Arab Emirates (UAE)., Julio Jose Montenegro, CEO of BlueGrace Energy Bolivia (BGEB), announced the acceptance of BlueGrace Energy Bolivia as member of the International Capital […]

Read More

Pacific Green Completes Transaction to Sell Its 99MW Richborough Energy Park Battery Development for £74 Million (US$93 Million)

DOVER, DE / ACCESSWIRE / June 28, 2023 / Pacific Green Technologies, Inc. (“Pacific Green”), (OTCQB:PGTK) announces that it has completed the sale of 100% of the shares in Pacific Green Battery Energy Parks 1 Limited (“PGBEP1”) to Sosteneo Fund 1 HoldCo S.à.r.l, an energy transition focused fund for £74 million (US$93 million). PGBEP1 is […]

Read More

South Africa’s “Oasis (Reach for Your Dreams)” Receives Recognition from UNAOC-BMW Group’s Intercultural Innovation Hub

BERLIN, GERMANY / ACCESSWIRE / May 25, 2023 / South African organization “Oasis: `Reach For Your Dreams`” is one of ten global grassroots recognized by the prestigious Intercultural Innovation Hub, a joint initiative of the United Nations Alliance of Civilizations (UNAOC) and the BMW Group, implemented with the support of Accenture, during a ceremony held […]

Read More

New Access Accelerated Global Collective Report Charts Path Forward in Fight Against Noncommunicable Diseases

Access Accelerated and Partners Unveil Findings From Six-Year Report GENEVA, SWITZERLAND / ACCESSWIRE / May 24, 2023 / Access Accelerated, a pioneering collective of leading biopharmaceutical and life science companies dedicated to confronting the growing global noncommunicable disease (NCD) crisis, announced the release of a six-year report: Key Lessons in Advancing Access to NCD Care: […]

Read More